US Patent Issued to GLAX Health on May 20 for "Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer" (Delaware, Texas Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,494, issued on May 20, was assigned to GLAX Health LLC (Lewes, Del.).

"Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer" was invented by Shivani Shrivastava (Wilmington, Del.) and Rakesh K Srivastava (Tyler, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of compositions for monitoring, diagnosis, detecting, and treating a cancer condition in a subject. The use of composition comprises methods of monitoring, diagnosis, and detecting cancer and inflammation with EN2 and/or SATB2 expression and/or activity. The pharmaceutical composition will further compris...